Qrons Valuation
| QRON Stock | USD 0.18 0.01 5.26% |
Qrons seems to be overvalued based on Macroaxis valuation methodology. Our model determines the value of Qrons Inc from analyzing the company fundamentals such as Return On Asset of -14.92, shares owned by insiders of 76.14 %, and EBITDA of (859.09 K) as well as examining its technical indicators and probability of bankruptcy. . In general, most investors support obtaining undervalued entities and abandoning overvalued entities since, at some point, asset prices and their ongoing real values will merge together.
Overvalued
Today
Please note that Qrons' price fluctuation is out of control at this time. Calculation of the real value of Qrons Inc is based on 3 months time horizon. Increasing Qrons' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Qrons otc stock is determined by what a typical buyer is willing to pay for full or partial control of Qrons Inc. Since Qrons is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Qrons OTC Stock. However, Qrons' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.18 | Real 0.15 | Hype 0.18 | Naive 0.19 |
The intrinsic value of Qrons' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Qrons' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Qrons Inc helps investors to forecast how Qrons otc stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Qrons more accurately as focusing exclusively on Qrons' fundamentals will not take into account other important factors: Qrons Total Value Analysis
Qrons Inc is at this time estimated to have valuation of 7.05 M with market capitalization of 6.68 M, debt of 370 K, and cash on hands of 8.35 K. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Qrons fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
7.05 M | 6.68 M | 370 K | 8.35 K |
Qrons Asset Utilization
One of the ways to look at asset utilization of Qrons is to check how much profit was generated for every dollar of assets it reports. Qrons holds a negative application of assets of -14.92 pct., losing $0.15 for each dollar of assets held by the company. Inadequate asset utilization implies the company is being less effective with each dollar of assets it holds. Put it differently, asset utilization of Qrons Inc shows how discouraging it operates for each dollar spent on its assets.Qrons Ownership Allocation
Qrons holds majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 76.14 pct. of Qrons Inc outstanding shares that are owned by insiders implies they have been buying or selling the stock in recent months in anticipation of some upcoming event.Qrons Profitability Analysis
Net Loss for the year was (1.07 M) with profit before overhead, payroll, taxes, and interest of 0.About Qrons Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of Qrons Inc. In general, an absolute valuation paradigm, as applied to this otc stock, attempts to find the value of Qrons Inc based exclusively on its fundamental and basic technical indicators. By analyzing Qrons's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of Qrons's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of Qrons. We calculate exposure to Qrons's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Qrons's related companies.Qrons Inc., a biotechnology company, engages in development of biotech products, treatments, and technologies to combat neuronal diseases. Qrons Inc. was incorporated in 2016 and is based in Long Island City, New York. Qrons operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 2 people.
8 Steps to conduct Qrons' Valuation Analysis
OTC Stock's valuation is the process of determining the worth of any otc stock in monetary terms. It estimates Qrons' potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of otc stock valuation is a single number representing a OTC Stock's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Qrons' valuation analysis, follow these 8 steps:- Gather financial information: Obtain Qrons' financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Qrons' revenue streams: Identify Qrons' primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Qrons' industry and market trends, including the size of the market, growth rate, and competition.
- Establish Qrons' growth potential: Evaluate Qrons' management, business model, and growth potential.
- Determine Qrons' financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the OTC Stock's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Qrons' estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Qrons Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 13.3 M | |
| Quarterly Earnings Growth Y O Y | 0.946 | |
| Retained Earnings | -8.8 M | |
| Shares Float | 2.3 M |
Other Information on Investing in Qrons OTC Stock
Qrons financial ratios help investors to determine whether Qrons OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Qrons with respect to the benefits of owning Qrons security.